Array BioPharma, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Array BioPharma, Inc. - overview
Established
1998
Location
Boulder, CO, US
Primary Industry
Biotechnology
About
Established in 1998 and based in US, Array BioPharma, Inc. operates as a biopharmaceutical company that provides targeted small molecule drugs. The company cooperates with AstraZeneca, Eli Lilly and Genentech, etc. In 2000, it was listed on the NASDAQ.
The company cooperates with Siemens, Fuji Electric and Hager etc. In June 2019, Pfizer Inc. announced to acquire Array BioPharma, Inc. The company provides targeted small molecule drugs for patients with cancer and other high-burden diseases.
Its products include BRAFTOVI® (encorafenib) capsules and MEKTOVI® (binimetinib) tablets. It has over 30 clinical trials, including encorafenib and binimetinib clinical programs.
Current Investors
Amgen Inc., Deerfield Capital Management, Novartis International AG
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Dermatology, Pharmaceutical Research & Development
Website
www.arraybiopharma.com
Verticals
HealthTech, Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Array BioPharma, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman Of The Board | BM | ||||||
| Chairman of the Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.